Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone added to ACE inhibition in chronic kidney disease with hypertension
2012-002175-34Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in chronic kidney disease (CKD), hypertension (HTN), sponsored by Medical University of Vienna. Started Sep 2012; status: completed.
02
Drugs
eplerenone
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on 2012-002175-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002175-34.